AFP and hepatocellular carcinoma: In a separate meta-analysis conducted in 2020, the combined use of AFP, AFP-L3, and DCP demonstrated a high diagnostic efficacy in discriminating HCC, with a pooled sensitivity of 0.88, specificity of 0.79, and an AUC of 0.91 [57].